nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2007, 04, 262-266
造影剂肾病预防的研究进展
基金项目(Foundation):
邮箱(Email):
DOI: 10.19577/j.cnki.issn10074406.2007.04.024
发布时间: 2007-07-25
出版时间: 2007-07-25
移动端阅读
摘要:

关键词:
Abstract:

KeyWords:
参考文献

[1]Berg KJ.Nephrotoxicity related to contrast media[J].Scand J UrolNephrol,2000(5),34:317.

[2]Lin J,Bonventre JV.Prevention of radiocontrast nephropathy[J].CurrOpin Nephrol Hypertens,2005,14(2):105.

[3]Aspelin P,Aubry P,Fransson SG,et al.Nephrotoxic effects in high-risk patients undergoing angiography[J].N Engl J Med,2003,348(6):491.

[4]Haeussler U,Riedel M,Keller F.Free reactive oxygen species andnephrotoxicity of contrast agents[J].Kidney Blood Press Res,2004,27(3):167.

[5]刘冬舟,贾汝汉,丁国华,等.造影剂激活p38信号通路诱导肾小管细胞凋亡[J].中华肾脏病杂志,2004,20(4):113.

[6]Panos N,Elias I,George A.Contrast media induced nephropathy in pa-tients undergoing cardiac catheterisation[J].Hellenic J cardiol,2004,45(6):107.

[7]Aspelin P,Aubry P,Fransson S,et al.Nephrotoxic effects in high-riskpatients undergoing angiography[J].N Eng J Med,2003,348(6):491.

[8]Solomon R.The role of osmolality in the incidence of contrast-inducednephropathy:a systematic review of angiographic contrast media in highrisk patients[J].Kidney Int,2005,68(5):2256.

[9]Trivedi HS,Moore H,Nasr S,et al.A randomized prospective trial toassess the role of saline hydration on the development of contrast nephro-toxicity[J].Nephron Clin Pract,2003,93(1):C5.

[10]Mueller C,Buerkle G,Buettner HJ,et al.Prevention of contrast me-dia-associated nephropathy:randomized comparison of 2 hydration regi-mens in 1620 patients undergoing coronary angioplasty[J].Arch InternMed,2002,162(3):329.

[11]Merten GJ,Burgess WP,Gray LV,et al.Prevention of contrast-in-duced nephropathy with sodium bicarbonate[J].JAMA,2004,291(19):2328.

[12]Asif A,Epstein M.Prevention of radiocontrast-induced nephropathy[J].Am J Kidney Dis,2004,44(1):12.

[13]Norman EL,Vandana SM.Radiocontrast nephropathy[J].Curr IntervCard Rep,2000,2(4):335.

[14]Kini AA,Sharma SK.Managing the high-risk patient:experience withfenoldopam,a selective dopamine receptor agonist,in prevention of ra-diocontrast nephropathy during percutaneors coronary intervention[J].Rev Cardiovasc Med,2001,2(Suppl 1):S19.

[15]Stone G,McCullough P,Tumlin J,et al.Fenoldopam mesylate for theprevention of contrast-induced nephropathy:a randomized controlledtrial[J].JAMA,2003,290(17):2284.

[16]Vincent L.Radiocontrast media-induced nephrotoxicity in patients withrenal failure:rationale for a new double-blind,prospective,randomizedtrial testing calcium channel antagonists[J].Nephrol Dial Transpl,2002,17(8):1362.

[17]Koch J,Plum J,Grabensee B,et al.Prostaglandin E1:a new agentfor the prevention of renal dysfunction in high risk patients caused byradiocontrast media?[J].Nephrol Dial Transpl,2000,15(1):43.

[18]Huber W,Ligman K,Page M,et al.Effect of theophylline on contrastmaterial induced nephropathy in patients with chronic renal insufficien-cy:controlled randomized,double-blinded study[J].Radiology,2002,223(3):772.

[19]Drager LF,Andrade L,Barros de Toledo JF,et al.Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy:decrease inoxidant stress-mediated renal tubular injury[J].Nephrol Dial Trans-plant,2004,19(7):1803.

[20]Tepel M,Van der Giet M,Schwarzfeld C,et al.Prevention of radio-graphic contrast agent induced reductions in renal function by acetylcys-teine[J].N Engl Med,2000,343(3):180.

[21]Kay J Chow W,Chan T,et al.Acetylcysteine for prevention of acutedeterioration of renal function following elective coronary angiographyand intervention:a randomized trial[J].JAMA,2003,289(5):553.

[22]Diaz-Sandovol L,Kosowsky B,Losordo D.Acetylcysteine to preventangiography related renal tissue injury.(The APART trial)[J].Am JCardiol,2002,89(3):356.

[23]Briguori C,Manganelli F,Scarpato P,et al.Acetylcysteine and con-trast agent associated nephrotoxicity[J].J Am Coll Cardiol,2002,40(2):298.

[24]Baker C,Wragg A,Kumar S,et al.A rapid protocol for the preven-tion of contrast-induced renal dysfunction:The RAPPID study[J].JAm Coll Cardiol,2003,41(12):2114.

[25]Birck R,Krzossok S,Markowetz F,et al.Acetylcysteine for preven-tion of contrast nephropathy:meta-analysis[J].Lancet,2003,362(9384):598.

[26]Vogt B,Ferrari P,Schonholze C,et al.Prophylactic hemodialysis afterradiocontrast media in patients with renal insufficiency is potentiallyharmful[J].Am J Med,2001,111(9):692.

[27]Frank H,Werner D,Lorusso V,et al.Simultaneous hemodialysis dur-ing coronary angiography fails to prevent radiocontrast-inducednephropathy in chronic renal failure[J].Clin Nephrol,2003,60(3):176.

[28]Marenzi G,Marana I,Lauri G,et al.The prevention of radiocontrast-agent-induced nephropathy by hemofiltration[J].N Engl J Med,2003,349(14):1333.

基本信息:

DOI:10.19577/j.cnki.issn10074406.2007.04.024

中图分类号:R595.3

引用信息:

[1]吉俊,丁小强.造影剂肾病预防的研究进展[J].中国临床药学杂志,2007(04):262-266.DOI:10.19577/j.cnki.issn10074406.2007.04.024.

发布时间:

2007-07-25

出版时间:

2007-07-25

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文